Calgary clinical trial looks to repair damage caused by multiple sclerosis

CALGARY- Calgary researchers are recruiting patients for a clinical trial, as they try to find a drug that can repair the damage caused by relapsing and remitting forms of multiple sclerosis.

The trial will test two drugs currently approved for use to treat other conditions.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

Sign up for weekly health newsletter Sign Up

By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

“One of them is called domperidone,” explains Dr. V Wee Yong, a neuroscientist with the Hotchkiss Brain Institute. “It’s currently used in Parkinson’s disease, but some time ago we also discovered the hormone prolactin can elicit repair in models of MS and this drug raises prolactin levels as a side effect.”

A sedative is also being tested.

Researchers will be recruiting patients through Calgary’s MS Clinic.

Anyone interested in learning more about this research and other studies can do so at the MS Connections Conference, which is being held in Calgary on September 19^th and 20^th.